Clinical Cases in Pharmacology Clinical Cases  ·  Cardiovascular  ·  Reperfusion Strategy  ·  Tenecteplase vs Reteplase, Rural STEMI
Cardiovascular, Case 0089 — Reperfusion Strategy

Fibrinolysis in a Combine Cab: Choosing the Bolus a Rural Night Shift Can't Miss

Both drugs would reasonably treat his STEMI. What actually decides between them tonight is which one survives a single nurse covering the entire department for the next thirty minutes.

Abbreviations, terms, and other agents mentioned in this case STEMI — ST-elevation myocardial infarction  ·  PCI — percutaneous coronary intervention  ·  ED — emergency department  ·  fibrin-specific — preferentially activates plasminogen already bound to fibrin within the clot, limiting systemic fibrinogen breakdown  ·  critical-access hospital — federally designated small rural hospital (25 beds or fewer), typically without on-site catheterization capability
Presentation

M.T., a 49-year-old man, was found slumped in the cab of his combine by his sixteen-year-old son during this week's wheat harvest — conscious, sweating, clutching his chest, unable to say for how long he'd been sitting there before his son climbed up to check on him. He has no prior cardiac history, works physically demanding farm labor most of the year, and by his own account has never seen a doctor for anything more serious than a broken wrist, having gone without regular checkups the way a lot of independent farmers do when the harvest schedule doesn't leave room for them. He arrived at the county's small critical-access hospital roughly forty minutes after his son found him, with an ECG showing anterior ST elevation and a story consistent with substantially longer symptom onset before that.

The nearest PCI-capable center is two and a half hours away by ground, and tonight's weather has grounded helicopter transport entirely — a fibrinolytic-first strategy isn't a preference here, it's the only option that fits within a guideline-relevant window. Both tenecteplase and reteplase are stocked and both are reasonable choices by drug mechanism alone; a recent retrospective cohort comparing the two in exactly this rural-access context found no difference in failed thrombolysis but meaningfully more major bleeding with reteplase, though the comparison was observational rather than a randomized head-to-head. What sharpens the decision beyond that bleeding signal is the administration itself: tenecteplase is a single weight-based bolus given once, while reteplase requires two separate boluses thirty minutes apart — and tonight, like most nights at this hospital, there is exactly one RN covering the entire emergency department.

M.T. · 49 Anterior STEMI, Rural Presentation
History
No prior cardiac history, physically active farm labor
Presentation
Found in combine cab by son, chest pain, diaphoretic, unknown exact onset time
ECG
Anterior ST elevation, leads V2–V5
Transport options
Nearest PCI center 2.5 hours by ground; helicopter grounded by weather
Staffing tonight
Single RN covering the entire ED
Weight
91 kg

At the rural ED, decision to lyse

Emergency Medicine Physician Opening

Given tonight's staffing, I want tenecteplase specifically. It's a single weight-based bolus, given once, and done — nothing that depends on anyone remembering a second dose thirty minutes from now while managing whatever else comes through that door. The retrospective rural-access data also showed more major bleeding with reteplase, which only reinforces the choice.

Clinical Pharmacologist Response

I don't disagree with tenecteplase tonight, but I want to be precise about why. That bleeding comparison was observational, retrospective, and small — not something I'd want us leaning on as if it were a randomized result. Reteplase's double-bolus dosing is well-established and effective when it's given correctly.

The real argument for tenecteplase tonight isn't the bleeding data, which I'd treat as suggestive at best — it's that a single-bolus drug removes a specific, known failure point from a night with exactly one nurse to catch it.

Emergency Medicine Physician Final

Agreed, and I'd frame it that way with the transferring cardiologist too — tonight's choice is about administration reliability given tonight's staffing, not a claim that reteplase is inferior in general. Tenecteplase, weight-based single bolus — 50 mg at his weight — with heparin, chewed aspirin, and a clopidogrel load alongside; clopidogrel is the P2Y12 inhibitor established with fibrinolysis, and ticagrelor and prasugrel have not been shown safe given at the time of lysis. Then transfer as soon as he's stable enough to move. Separately, this hospital needs a standing checklist for double-bolus thrombolytics regardless of which drug ends up stocked here, so staffing alone doesn't quietly become the deciding factor on nights like this one.

Regimen selected
Tenecteplase
Fibrin-Specific Fibrinolytic · Single weight-based IV bolus, 50 mg (the 90 kg and above tier) for 91 kg
Selected primarily for single-bolus administration given tonight's single-RN staffing; observational rural-access bleeding data also favored it.
Reteplase
Fibrin-Specific Fibrinolytic — Ruled Out, Tonight Specifically
Not ruled out on efficacy grounds — the double-bolus schedule (10 units, then 10 units 30 minutes later) carries real risk of a missed second dose given tonight's staffing.
Unfractionated Heparin
Anticoagulant, Weight-Based · Adjunct
Standard adjunct to fibrinolytic therapy, dosed to weight and continued through transfer.
Aspirin + Clopidogrel Loading
Antiplatelet Loading · Aspirin 325 mg chewed, clopidogrel 300 mg · Adjunct
Clopidogrel is the P2Y12 inhibitor with established safety and benefit alongside fibrinolysis (300 mg load at age under 75); ticagrelor and prasugrel are not substitutes in this setting.
Where this was left

Tenecteplase given as a single weight-based bolus, 50 mg at 91 kg, with heparin plus aspirin 325 mg chewed and clopidogrel 300 mg loading alongside. Transfer to the PCI-capable center initiated once he was hemodynamically stable enough to move.

Agreed on the drug choice; not agreed as fully resolved was the underlying system problem it exposed, named explicitly as a follow-up item rather than left implicit:

A standing double-bolus-timer checklist and protocol for reteplase (or any two-dose thrombolytic) was flagged as needed at this facility regardless of tonight's specific choice, since staffing realities like tonight's are not unusual here and shouldn't be the deciding factor by default every time.

Educational content only — a composite teaching case, not a real patient encounter or a substitute for clinical guidance. About These Cases →